Access to investigational medicines
Our focus is on enrolling patients in clinical trials to obtain the data required to enable regulatory and reimbursement authorities to review and decide...
Alcon Understanding Clinical Trials
Alcon conducts clinical trials to evaluate the safety and efficacy of our products. These clinical studies are fundamental to driving innovation and developing products...
Allergan and Humana Announce Research Partnership to Improve Health Outcomes
Allergan plc (NYSE: AGN), a leading global specialty pharmaceutical company, today announced a multi-year research collaboration with Humana Inc. (NYSE: HUM), one of the...
Research & development at sun pharma
We were pioneers among Indian pharmaceutical companies to see tremendous value in investing in research & development (R&D). Our early investments in R&D, beginning...
Strengthen return on investment through operational efficiency
In addition to ensuring that Amgen's investment decisions are based on compelling science, we are reengineering our processes to operate more efficiently. This ongoing...
Pursue a “Biology First” approach to choose the right targets and tools
At Amgen, we believe drug discovery starts with a deep understanding of biology. This understanding guides the critical choice of which disease target to...
Refocus and differentiate our Discovery Research efforts
At a time when technological breakthroughs are revolutionizing how drugs are discovered, Amgen's strategy aims to fully exploit the emerging opportunities. We have made...
Subscribe Our Newsletter
White Papers
The Future of Digital Health
The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....
Five Best Practices to Deliver Exceptional Multichannel Experiences
A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...
The Impact and Use of Social Media in Pharmacovigilance
Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...